chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Continuously vomiting; Chills one minute and then sweating the next; Chills one minute and then sweating the next; Frightened; This is a spontaneous report from contactable nurse. An 80-year-old female patient (reporter's mother) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter's mother was just horribly ill and they do not know if they should be taking her to the emergency room. They do not know if there was some kind of medication they can give her to help her. She is continuously vomiting, she has the chills one minute and then sweating the next. "She is asking me to take her report and mentally I do not know she is so frightened because of the severity of these symptoms or that there is something really bad going on". Outcome of the events was unknown.   Information on the lot/batch number has been requested.
both of my feet are swollen, the right foot is swollen and the left foot is swollen; these knees are swollen.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.   A 73 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 26Apr2021 (Lot number: EW0164) at the age of 73 years as single dose for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: PERIPHERAL SWELLING (non-serious) with onset 26Apr2021, outcome "unknown", described as "both of my feet are swollen, the right foot is swollen and the left foot is swollen"; JOINT SWELLING (non-serious) with onset 26Apr2021, outcome "unknown", described as "these knees are swollen.". Therapeutic measures were not taken as a result of peripheral swelling.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021499344 Same reporter/drug ,different patient
Needle was loose; vaccine drip on arm; vaccine drip on arm; A spontaneous report was received from a health care provider concerning a 30 year old, female patient who received less than 2nd dose of Moderna Vaccine on (03Feb2021) because syringe leaked a few drops. This HCP did not administer the doses.    The patient's medical history was not provided.  Concomitant product use was not provided by the reporter.    The patient received their first of two planned doses of mRNA-1273 (Batch number not provided) on 06/Jan/2021.  On 03Feb2021, approximately one month later, the patient received their second of two planned doses of mRNA-1273 (Batch number not provided) for prophylaxis of COVID-19 infection. Nurse stated that needle was loose and full dose was not given because she noticed part of the vaccine that dripped out onto patients arm.   Treatment information was not provided.     The patient received both scheduled doses of mRNA-1273 prior to the event(s); therefore, action taken with the drug in response to the event(s) is not applicable.  Action taken with mRNA-1273 in response to the event was not applicable.   The outcome of the event, Needle was loose and vaccine drip on arm was considered resolved on an unreported date.; Reporter's Comments: This case concerns a 30 year old female patient who received second dose of the vaccine and experienced vaccine drip on arm due to needle being loose. There were no reported adverse events in this case of syringe issue and exposure via skin contact.
No adverse side effectes were reported; HCP called to report a TE for VAXNEUVANCE (Lot #W039033; Expiration 10/01/2024; current excursion (49.1F) for 34 minutes; with two previous excursions at (35.9F) for 2 minutes and again at (35.9F) for 2 minutes) and ROTATEQ (Lot #1968385; Expiration; This spontaneous report was received from a medical assistant and refers to a 4 month old male patient. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported.   On 08-JUN-2023, the patient was vaccinated with pneumococcal 15v conj vaccine (crm197)(VAXNEUVANCE) 0.5 mL (lot # W039033, expiration date: 01-OCT-2024) in the left thigh (route of administration not provided); and with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 2 mL (lot # 1968385, expiration date: 22-MAY-2024), orally, both as prophylaxis; which underwent a current temperature excursion at 49.1 Fahrenheit (F) for 34 minutes (with 2 previous temperature excursions at 35.9 F for 2 minutes each). No adverse side effects were reported for the patient.
During 30 minutes observation after member received 1st dose of Covid-19 vaccine member stated she felt very sluggish. Member appeared listless and slow speech. Rapid response team/Adult emergency notified. Vitals obtained 124/76 Pulse 71, 100% RA. Member transferred to the health professional care  via wheelchair.
HIGH BLOOD PRESSURE; PULSATING FEELING ALL OVER THE BODY; FAST HEART RATE; This spontaneous report received from a patient concerned a African American, Not Hispanic or Latino female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 65A21A, and expiry: unknown) 1 total dose was, administered at right arm on 03-MAY-2021 for prophylactic vaccination and felt fine. No concomitant medications were reported. On unspecified date in MAY-2021, it was reported that her husband took the second shot of the Moderna vaccine and had symptoms. She took him to urgent care and told the nurse that she had the JNJ and the nurse said omg (oh my god) can't believe you had that. The patient was felt like her heart was beating extremely fast (first heart rate) but when her pulse were checked by the nurse at urgent care it was good, it had not stopped ever since. She experienced high blood pressure (high blood pressure) when they checked her blood pressure in the hospital it was like 216, it keeps going up and down. She did not know how long this would continue and if it was a side effect or not. It does not hurt but felt annoying as she developed a pulsating feeling all over the body (pulsating feeling all over the body). She was treated with blood pressure medication, blood thinners (unspecified) and was something (unspecified) to slow her heart rate down.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from first heart rate, and the outcome of high blood pressure and pulsating feeling all over the body was not reported. This report was serious (Other Medically Important Condition.; Sender's Comments: V0-20210526496-covid-19 vaccine ad26.cov2.s-High Blood Pressure. This event is considered Un assessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
COVID infection. Specimen collected 8/8/21. Patient died on 8/11/21.
Ever since she got the Vaccine acid reflux reported as side effects; she is been like very tight and just like a burning sensation burning, like heartburn; Ever since she got the Vaccine acid reflux reported as side effects; she is been like very tight and just like a burning sensation burning, like heartburn; Ever since she got the Vaccine acid reflux reported as side effects; she is been like very tight and just like a burning sensation burning, like heartburn; Ever since she got the Vaccine acid reflux reported as side effects; she is been like very tight and just like a burning sensation burning, like heartburn; This is a spontaneous report received from a contactable consumer. A 18-Year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173, Expiry Date: 31Aug2021), via an unspecified route of administration, administered in right arm on 28May2021 (at the age of 18 years old) as a single dose for COVID-19 immunisation. The patient's medical history included Type 1 diabetes mellitus and Anxiety from an unknown date and unknown if ongoing. The patient's concomitant medication included Humalog (INSULIN LISPRO) taken for Type 1 diabetes mellitus and zoloft (SERTRALINE HYDROCHLORIDE) taken for anxiety, start date and stop date was not reported. The patient had not received any prior vaccinations within 4 weeks. On an unspecified date the patient experienced ever since she got the Vaccine acid reflux reported as side effects; she has been like very tight and just like a burning sensation burning, like heartburn. The patient reported the patient did not know this question or not patient's daughter and they got the first dose of Pfizer Vaccine this past Friday. The patient's daughter is 19 years old and the patient ever since got the Vaccine. The patient could not find anywhere was any suggestions acid reflux was that thing reported as side effects. The patient received antacid like a Pepcid as treatment for the events. The patient underwent lab tests and procedures which included blood test on 02Jan2021. The outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
Mild to severe lingering pain at the injection site and up into left shoulder.; Mild to severe lingering pain at the injection site and up into left shoulder.; This is a spontaneous report received from a contactable consumer (patient) via COVID-19 Adverse Event Self-Reporting Solution. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration, in the left arm on 02Apr2021 at 13:15 (at the age of 40-years-old) as a single dose for COVID-19 immunization. Medical history included allergy to nuts and grass. Concomitant medications included ibuprofen (MANUFRATURER UNKNOWN) from an unknown date and for unknown indication taken within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 02Apr2021, the patient experienced mild to severe lingering pain at the injection site and up into left shoulder. Patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of mild to severe lingering pain at the injection site and up into left shoulder was  resolving.   No follow-up attempts are needed; information about lot number cannot be obtained.
Blood clot formation in left calf 4 days after receiving first dose of the Covid shot. Started as pain in the left calf and progessivley got worse between Monday 9/6/2021 and Friday 9/10/2021. Went to the ER on 9/11/2021. Currently on Eliquis for 3 months. I do not have a history of any blood related issues. I have always had good blood pressure.
Extremely heavy menstrual cycles for over a year, bleeding trough tampons and onto clothes and bedding. Overly painful cramping which is not normal for me. Large blood clots during cycle.
Blood Clot in my lower right leg. Which can be life threatening if it were to dislodge and travel to the lungs and or Heart.   Treatment: 30 day starter pack Eliquis 5mg tabs blood thinner, Methylprednisone 4mg dospak 21s, Acetaminophen 325mg  2@-6hrs or as needed
This spontaneous report as received from a physician refers to a 28 year old female patient. The patient, who was indicated to receive a tuberculin skin test (PPD), received 0.1 ml of PNEUMOVAX 23 injection, intradermally (lot # K007773, expired date: 01-MAY-2015) in her left forearm in error on 01-OCT-2014. Concomitant therapy was not reported. The physician stated that the vial of PENUMOVAX 23 had been placed in the PPD vial's carton, and she didn't look at the label of the vial until after the 0.1 ml of PNEUMOVAX had been administered to the patient, when she was documenting the administration. The physician was certain that the PNEUMOVAX 23 vial was not supplied in the PPD carton, so there was no PQC. The physician stated that she did not confuse the PNEUMOVAX 23 with the PPD product; she didn't check the label of the PNEUMOVAX 23 vial prior to administration of the 0.1 ml dose of PNEUMOVAX intradermally. After the physician recognized the error, she administered the tuberculin skin test on the patient's other forearm during the same visit. No adverse effect has been observed or reported. The outcome of adverse event was not reported. The relationship between adverse event and PNEUMOVAX 23 was not reported. Additional information has been requested.
Nausea, arm pain, throbbing in my right femoral artery in groin area. I was sitting at my desk looking at my computer and when I got up from my groin to my toes of my right leg were completely numb and weak, I could not walk on it, so I went to the Emergency room.
Information has been received from a pharmacist concerning a 57 year old male who in 1992 was vaccinated with a 1st dose and on 10/25/01 was vaccinated with a 2nd dose of pneumococcal vaccine 23 polyvalent. On 10/27/01, the pt was admitted to the hospital with cellulitis. On 10/30/01, the pt was still hospitalized and was receiving treatment with vancomycin. The nurse reported that she was not certain of the pt's status as of 11/2/01. Additional information has been requested.
Intense fatigue, sleepiness for 24 hours post vaccine. Injection site pain /sore arm the following day
Severe stuffy nose; Pain in arm; Chills; Fatigue; Fever; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 07:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The medical history included depression, anxiety, diabetes and was 20 pounds overweight. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified medications for diabetes, depression and anxiety within two weeks of vaccination. On 23Apr2021, the patient experienced severe stuffy nose, pain in arm, chills, fatigue and fever. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe stuffy nose, pain in arm, chills, fatigue and fever was not resolved at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
She was actually had this exposure to someone who is positive; Found out that my granddaughter was tested for COVID and I was with her last night; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 07Oct2021 14:00 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Family history included: "COVID-19" (unspecified if ongoing), notes: granddaughter tested positive. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 Immunisation; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 Immunisation. The following information was reported: EXPOSURE TO SARS-COV-2 (non-serious) with onset 07Oct2021, outcome "unknown", described as "She was actually had this exposure to someone who is positive; Found out that my granddaughter was tested for COVID and I was with her last night".  Additional information: Transferring agent stated, "The patient got her caller on the other line and unfortunately she didn't provide her phone number. So, now her concern was that she already had the booster shot actually today 2 PM and unfortunately her granddaughter tested positive. Yeah, she was actually had this exposure to someone who is positive. She is asking if that's okay since she already got the booster shot?". Consumer stated, "Today, I received my booster shot, okay and at noon at 2 o'clock I got a call from my granddaughter who tested positive for COVID, was there a concern?" Consumer stated, "And she found out that her granddaughter was tested for COVID and she was with her last night (further clarification unknown if granddaughter got the COVID 19 Vaccine and got positive for COVID, hence split case not made), was there a concern?". Reporter seriousness for She was actually had this exposure to someone who is positive; Found out that my granddaughter was tested for COVID and she was with her last night: Unspecified.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
4 hours after injection, severe pain started from the site. 2 hours later started with chills and fever. At 7 am the next morning, fever, weakness, and crippling headache with severe nausea. Stayed that way for 24 hours. Fever stopped first. Weakness, headache and nausea slowly got better over the next 48 hours. Had to call in sick for work. Of note, I was also given the flu vaccine at the same time as the SHINGRIX.
Client came in with siblings to get back to school immunizations with grandma. Grandma brought all 3 sibling backs, another nurse was in the room with me helping with vaccines.  Clients sister, who is 16 was suppose to get Bexsero not the 11 year old client. 11 year old client jumped on the bed,   Client was asked name and DOB, grandma confirmed. When nurse called for client, client jumped on the bed and nurse asked name again, client and grandma confirmed named (although, it was the wrong name) and nurse gave bexsero to wrong client. Client and grandma was notified that Bexsero was given to wrong client.  Clients grandma stated, they were not paying attention when nurse asked what the clients name was, and that its okay she received the Bexsero immunization early. Educated client that although she received the vaccine early, it is safe for ages 10 and up who are in the high risk or traveling. Educated client and grandma an adverse reactions to watch for. Client had no reactions to the vaccination during visit. A follow up will be made with the client. Dr. was notified about medication Error.
Patient admitted for decompensated schizoaffective disorder; Patient was using methamphetamine and medication noncompliant. Behavioral health admission and treatment. Hospital admission within 6 weeks of receiving the COVID vaccine,
About weeks after my 3rd vaccine dose, I was found to have anemia on a finger stick hemoglobin when I went to donate blood. I had a venous draw done later that day and confirmed the anemia.
A report was received from a health professional on 10/31/2001, concerning a female patient of unknown demography who was inadvertently administered the Fluvirin vaccine whi1st 23 weeks pregnant, on an unknown date. On unknown date, the patient received the Fluvirin vaccine whi1st 23 weeks pregnant. No further information was given. There was insufficient information to determine the reporter's causality assessment.
throughout the day the pain does not go away with medication; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 26Dec2021 16:30 (Lot number: 331308a) at the age of 37 years as dose 3 (booster), single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: ew982, Location of injection: Arm Left, Vaccine Administration Time: 11:00 AM), administration date: 17May2021, when the patient was 37 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: en9581, Location of injection: Arm Left, Vaccine Administration Time: 04:00 AM), administration date: 26Apr2021, when the patient was 37 years old, for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 30Dec2021 17:00, outcome "not recovered", described as "throughout the day the pain does not go away with medication"; HEADACHE (non-serious) with onset 30Dec2021 17:00, outcome "not recovered", described as "headache". Therapeutic measures were not taken as a result of pain, headache.  Additional information: The patient reported that after 5 days that she took the third dose of the covid-19 vaccine, and so far, she had a lot of headache, throughout the day the pain does not go away with medication, she never had a headache in her life, she was very worried. She reported "arm", which is "Privacy" in Privacy.   No follow-up attempts are possible. No further information is expected.
1st dose May2022, 2nd not yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 58-year-old female patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Twinrix (1st dose received on May 2022).   On an unknown date, the patient did not receive the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 25-OCT-2022 Reporter's Comment: HCP called to ask for information about the second dose of Twinrix in a patient who received the first dose in May 2022. The second dose was not administered a month later as stated in the prescribing information.  HCP asked if the patient could receive the second dose or if the vaccination had to start over.  The reporter did not provide the lot number and expiration date of the first dose of the Twinrix vaccine. The reporter did consent to follow up. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
Tested positive for Covid; Tested positive for Covid; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Tested positive for Covid". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive.  Clinical course: Tested positive for Covid recently and had mild cold symptoms and loss of taste/smell. Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200028500 same drug/event, different patient